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printing of polyurethane stents in a hospital and printing in-
dividual extrusion molds for silicone stents in a certified 
cleanroom are both feasible. Furthermore, there are promis-
ing attempts of combining mechanically customized stents 
with surface modifications, drug-eluting features, biode-
gradability, and time-dependent adaptation (4D printing). 
Truly optimized airway stents with the potential of solving 
the well-known stent problems such as granulation tissue 
formation, remodeling, mucostasis, and infections are in 
reach. The technical hurdles are probably easier to overcome 
than the legal constraints. The legal situations are discussed 
from a physician’s and a manufacturer’s perspective. 
 © 2017 S. Karger AG, Basel 
 Introduction 
 Bronchoscopic insertion of tracheobronchial stents is 
established as the standard of treatment option for pa-
tients suffering from central airway obstructions due to 
extrinsic compression. Often combined with resection 
 Keywords 
 Customized airway stents · Additive manufacturing · 
3D-printed stents · Drug-eluting stents 
 Abstract 
 Stent placement has been established as a standard proce-
dure for treating airway obstructions. Other indications are 
localized malacias and fistulas. Though many different stents 
with various diameters and lengths are available, the shapes 
are hardly ever ideal because of the distorted anatomy in 
patients with diseased airways. There are technical and legal 
limitations for customizing purchased airway stents. Individ-
ually tailored stents would be preferable. New techniques of 
additive manufacturing such as 3D printing make it possible 
to produce optimized stents for a particular patient. Using 
CT data and bronchoscopic images, stents can be construct-
ed that match a particular anatomical situation and apply 
the optimized expansion force. We give an overview of the 
currently available manufacturing techniques for polymeric 
stents and report about our own experience. Direct on-site 
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techniques such as laser or argon plasma coagulation, 
stents are placed to maintain airway patency by counter-
acting the constricting forces of tumors, lymph nodes or 
scar strictures as seen in benign stenosis. Other indica-
tions for stents are airway fistulas and dehiscences. In 
these cases, endoprostheses are placed to seal the trachea 
or bronchi against the esophagus or the pleural cavity 
 [1, 2] .
 A plethora of stents from various materials are com-
mercially available. Airway stents come in different 
lengths and diameters, are balloons or self-expanding, 
and are made from polymers or metals  [2, 3] . However, 
almost all stents are straight and round-shaped. For regu-
lar cases, this is a reasonable compromise but frequently 
a more anatomically shaped, bended, twisted or tapered 
stent would be more appropriate. The trachea is basically 
horseshoe-shaped and the bronchi get more and more 
round-shaped after each branching  [4] . Diseased airways 
are always deformed; in cases of benign strictures, they 
are typically triangular, slit or A-shaped  [5, 6] . With the 
exceptions of bifurcated stents and Montgomery T-tubes, 
all stents are held in place by friction resulting from the 
expansion force they apply on the airway wall. This con-
tact pressure impairs the microcirculation, which is most 
likely the main reason why granulation tissue develops 
 [6–8] . Probably equally harmful are scratching move-
ments of stent edges over the mucosa when the patient is 
breathing or coughing. In irregularly shaped stenotic ar-
eas, stents apply the highest pressure on the already dam-
aged tissue (narrowest part), while the end parts move 
slightly over the originally healthy mucosa. Ideally, a stent 
would match the shape of the stenotic airway, adapt well 
and would exert different forces over its length in order 
to establish airway patency without creating further tissue 
damage. In some cases, only little structural augmenta-
tion is required while in others the stent must work 
against a powerful neoplastic compression or fibrous 
scaring. In order to seal fistulas, mild wall contact without 
stretching would be ideal. A possible solution would be a 
stent tailored to the particular anatomy with optimized 
expansion force varying over its length and circumfer-
ence. In this technical paper, we outline how such a stent 
can be made using the emerging techniques of rapid man-
ufacturing and 3D printing.
 Past to Present 
 For the last 30 years, we had quite often encountered 
situations where normal stents could not solve the clinical 
problem. Examples are patients with pneumonectomies 
who had recurrences or stump fistulas. As J-shaped stents 
had not been available, we used tracheal and bronchial 
Dumon silicone stents which we cut and glued together 
( Fig. 1 a). In the pioneering days of stenting, legal aspects 
did not play a role. Today, nobody would dare to insert a 
stent which had been produced with industrial silicone 
glue in the operating room. Fifteen years ago, the indus-
trial partners had developed laser cutting techniques to 
produce tailored metal stents. They were produced after 
a patient-specific prescription and a sketch from the 
bronchoscopist. These stents had been made with the 
same validated manufacturing process as the standard 
stents. Delivery time was in the range of a few weeks and 
the costs could hardly be justified. Of course, these indi-
vidualized stents had not undergone all the tests that their 
normal CE-marked family members had passed. Basical-
ly, it was a favor done by the industrial partners and the 
patient had abstained from his liability rights in order to 
get the best possible device based on the judgement of the 
a b c
 Fig. 1.  a J-stent “bedside made” by gluing 
together two Dumon stents with appropri-
ate lengths, diameters and angle.  b Cus-
tom-made nitinol stents for a patient with 
dehiscence by laser cutting and forming. 
 c Individualized wire stent with modified 
angles and diameters for a patient with 
complex airway stenosis. 
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treating physician. The current step of evolution had been 
reached when stent manufacturers offered modifications 
of their existing products. The physician fills out a form 
and sends it to the stent manufacturer.  Figure 1 c shows as 
an example of a self-expanding bifurcated wire stent with 
limbs in different diameters and angles in two planes. We 
had implanted that particular stent in a girl with kypho-
scoliosis who could not be treated with any off-the-shelf 
product. Similar problems were solved in patients with 
tracheobronchomegaly when we needed stents with ex-
treme diameters (26 mm) or in patients with stump fistu-
las when we requested J-shaped stents with uncommon 
angles. This type of service is currently provided by man-
ufacturers of silicone stents and wire stents in Europe. 
Usually, within 2–4 weeks after sending a prescription, 
the hospital receives a custom-made, sterilized stent for 
the individual patient at affordable costs. Standard instru-
ments and insertion techniques can be used. However, 
the degrees of modifications are limited. All the currently 
available modified stents are still straight and round-
shaped and they have a fixed expansion force. In order to 
get closer to the real anatomy, we have explored the tech-
niques of 3D printing.
 Present to Future 
 Basically, all established techniques of manufacturing 
are based on either subtractive, casting, deforming (re-
shaping) or additive techniques. Making a sculpture by 
removing parts of a stone until the desired figure remains 
is an ancient example of a subtractive process. Material is 
scraped, grinded, turned, or machined from a block in 
order to create the final product. Producing a coronary 
stent by cutting a nitinol tube with a laser is a modern ex-
ample. The other basic manufacturing technique is shap-
ing or molding. The principle remains the same, whether 
clay is formed to a dish or steel is pressed to a car wing. 
Both require considerable postprocessing including sur-
face treatment until the desired function and appearance 
is attained. Finally there are additive techniques. Small 
pieces of materials are put together to create new stuff. 
Our ancestors managed to build a castle from stones and 
sand, students these days learn to build a smartphone. 
Especially this bottom-up principle seems to have no lim-
its. In 1998, researchers at IBM moved 35 single Xenon 
atoms with a tunneling microscope to form the 3 letters 
of their logo. Theoretically, medical nanotechnology is 
able to produce anything including the ultimate tracheal 
stent; however, it is not available to everybody today. 
 Rapid prototyping with 3D printing techniques had 
rapidly revolutionized designing processes in the con-
sumer industry during the last decade. In contrast to a 
simple computer-aided design (CAD) drawing displayed 
on a screen, a printed part allows a touch-and-feel experi-
ence as well as testing the mechanical handling feasibility 
of a future product. While in the beginning only model 
parts had been printed, we are now observing that more 
and more final products are made using the same tech-
niques. Orthopedic surgeons print prostheses  [9] and 
dentists teeth inlets  [10] . It has recently been demonstrat-
ed that a tracheal cannula can be manufactured based on 
image data of a patient  [11] . There is hardly any field in 
medicine that is not influenced by the new opportunities. 
The progress is so rapid that websites have been created 
which are almost daily updated in order to keep up with 
what is possible  [12] . A landmark in pulmonary medicine 
was the creation of a biodegradable airway splint that was 
surgically implanted in a child with bronchomalacia  [13, 
14] . The design and manufacturing was a complicated 
process that involved several disciplines and took a long 
time. We have been looking for ways to produce a stent 
that can be inserted bronchoscopically hours or at max 
days after the problem has been detected. It should be 
customized regarding the individual anatomy and have 
optimized biomechanical features for the specific condi-
tion. 
 Technical Considerations 
 The process of creating customized stents with 3D 
printing techniques can be divided into the following 
steps. 
 Image and Data Acquisition 
 First, anatomical data are collected to design the shape 
of the device. They can be derived from CT images or 
from the drawing of a bronchoscopist. Using a modern 
multidetector computed tomograph, high-resolution 3D 
image data can be acquired within a single breath-hold. 
The data are processed, for example, to present a model 
on the screen that is usually called virtual bronchoscopy. 
The current state of the art regarding these image-pro-
cessing techniques can be seen in navigation bronchos-
copy systems. Specialized companies such as Materialise 
(Leuven, Belgium) provide services to help clinicians. Al-
ternatively, measurements of stent-relevant dimensions 
can be made bronchoscopically and a simple drawing can 
be made by the endoscopist. This is certainly more de-
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manding when it comes to drawing curvatures, angles, 
and orientations. For more complex situations, CT-de-
rived virtual drawings are superior  [15] . In the case of 
severe malacia, it could be of benefit to measure real-time 
diameter under simulation of different ventilation pres-
sures and/or frequencies which can be done easily by jet 
catheter ventilation and cone beam CT-derived data ac-
quisition  [16] . In real clinical situations, a tumor will be 
removed and a stenosis will be dilated first. A preproce-
dure CT does not provide the data needed for the ideal 
stent. Length, shape and diameter of the diseased airway 
after the intervention will determine which stent dimen-
sions are appropriate. Thus, at least a second CT per-
formed after debulking and dilatation is necessary. Image 
data alone do not provide sufficient information about 
the rigidity of the airway structures and the technical fea-
sibility of a stent insertion. The touch-and-feel informa-
tion that only the bronchoscopist can deliver cannot be 
replaced by any image data.  
 CAD Designing 
 Following image acquisition and postprocessing, a 3D 
model is created with a CAD program. This is a critical 
step that requires the input of the treating physician. It 
would not help to design a stent that has the dimensions 
of the narrowed airway. After all, the stent shall counter-
act the constricting forces and open the airway. It would 
not be realistic either to create something that has normal 
diameters all along. The optimized prosthesis should 
match the dimensions of the nonaffected part but should 
be bigger at the location of the stenotic area. In addition, 
the expansion force should be greater at this location. 
Sealing a fistula, on the other hand, would be best accom-
plished with a soft and flexible part. For a stent made from 
a single polymeric material changing the tensile strength 
can only be accomplished by increasing the wall thick-
ness. It is obvious that the treating physician must have 
the ability to stretch or bend parts of the virtual cast and 
determine the local strength. There are no established 
techniques to calculate or even estimate the compressing 
force of a stricture. It depends on the experience of the 
practitioner to select the optimal recoil. In the presented 
stents the local recoil can be influenced by the wall thick-
ness. Thus, optimal stent designing software must pro-
vide the option to influence the material or the local wall 
thickness of the stent. This dream software should be able 
to import DICOM data but also have a smart user inter-
face where the bronchoscopist who has done the exami-
nation and pretreatment (e.g., laser resection or balloon 
dilatation) can influence the prosthesis. After all, the 
bronchoscopist must be able to implant the optimized 
prosthesis with available instruments. The software inter-
face must close the gaps between radiology data and prac-
titioner expertise as well as between medical aims and 
practicability, which might be limited by material avail-
ability and engineering tools. Several groups are working 
on these types of modeling software for airway stenoses 
with a graphical user interface  [16–18] .
 Generating a Construction File 
 In the next step, the model is electronically sliced into 
individual layers. A file containing this information is 
created that can be transmitted to a printer. This comput-
er-readable file can be transferred in any way (CD or via 
the internet). A typical file format is STL. There are pro-
grams checking the file for plausibility, removing unde-
sired overlays, closing possible gaps and adding support 
structures for free-standing or hanging parts. Finally, a 
device-specific code is generated that contains the in-
structions where and how much material shall be depos-
ited. 
 3D Printing 
 The fourth step depends on the printing technology. 
Stereolithography printers use photopolymers that are 
cured by an UV laser. The above-mentioned external air-
way stent had been produced with this technique. Selec-
tive laser sintering uses a high-power laser to fuse small 
particles of thermoplastic, glass or metal. While these 
techniques are ideal for creating models with finest de-
tails, the list of available materials is still short and the 
devices are comparably expensive. In the pharmaceutical 
field, there are attempts to develop soft stereolithography 
materials that can carry and release drugs. In the foresee-
able future, it should be possible to use these medical-
grade photocured polymers for the production of stents. 
For the time being, the most common technique in 3D 
printing is fused deposition modelling. A thermoplastic 
material usually from a spool is heated, melted and ex-
truded through a nozzle to form the 3D structure layer by 
layer. The printing material is deposited and bonded by 
the printer head until the final product can be removed. 
A second printer head can print support structures if 
needed. Precision and resolution are determined by the 
layer heights (typically 20–80 μm), material flow and oth-
er mechanical factors. With a semi-professional printer, 
wall thicknesses of 0.5 mm are easily achieved and a tra-
cheal stent with 60 mm length and complex shapes is 
printed in roughly 2–4 h. We used the Ultimaker 2 (Ulti-
maker, Geldermalsen, the Netherlands) and a modified 
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DualX (2PrintBeta, Konstanz, Germany) in our labora-
tory for the experimental stents. We also got stents print-
ed professionally by service providers (3D Medical Print-
ing AG, Pfäffikon, Switzerland). Their high-end ma-
chines achieved higher precisions and smoother surfaces 
for the price of outsourcing and delays. 
 Surface Treatment 
 The fifth step is surface treatment of the stents. Grind-
ing, polishing and dipping in solvents or liquid polymers 
have been used successfully. This depends on the printing 
material. In the beginning, when affordable printers be-
came available, only semi-rigid materials such as acrylo-
nitrile or polylactic acid could be used. Recently, truly 
flexible, rubberlike printing materials have become avail-
able enabling to print elastic stents with affordable and 
accessible equipment. Smoothing their surfaces without 
using toxic substances is not trivial. Before the prostheses 
can be implanted, they have to be cleaned. The remaining 
printing material, chemical solvents and any other poten-
tially harmful stuff must be carefully removed. 
 Sterilization 
 Of course, nothing should be implanted that might be 
contaminated. Vapor-based sterilization techniques can-
not be used since the melting temperature of most poly-
mers is too low. Plasma or ethylene oxide processes are 
ideal and can be applied in most hospitals or industrial 
manufacturing facilities. 
 Materials and Customization 
 A common grouping of stents is based on the material 
they are made of. Even the reimbursement and coding 
systems distinguish between metal, polymer and hybrid 
stents. 
 Most modern metallic stents are made of nitinol, a 
shape memory alloy with superelastic properties. These 
stents are either woven from nitinol wire or cut out of a 
nitinol tube, then dilated and formed until they have the 
desired shape. Next, they are crimped down to a diameter 
that allows delivery through a catheter. After deployment, 
these self-expanding stents regain their original shape. 
Because of their favorable mechanical characteristics, ni-
tinol stents have replaced older metal stents  [1, 3, 19] . It 
is not possible to modify such a stent once it is inside its 
delivery catheter. Not even its length can be adjusted by 
the physician. Customizations as illustrated in  Figure 1 b 
have to be made by the manufacturer. Changes require 
reprogramming the cutting laser and the complete pro-
duction of a forming tool, which makes this approach 
hardly feasible and very expensive. 
 The other classes of materials are polymers. These are 
long-chain molecules consisting of many small repeating 
units. The physical and biological behavior does not only 
depend on the chemical structure of the monomer but 
also on the degree of polymerization. Temperature has an 
influence on the tensile properties (how stiff, brittle or 
rubbery the material is and when it will break)  [20] . Many 
different polymers are used in medicine, taking advan-
tage of their specific properties. Hard contact lenses are 
made of polymethyl methacrylate, which is rigid, while 
tubes and drains are usually made from polyvinyl chlo-
ride, which is very flexible but not stretchable. Nonde-
gradable suture threads are made from polypropylene be-
cause its high tensile strength and heart valves are made 
from polydimethylsiloxane, which is extremely flexible 
and has unmatched fatigue resistance. Polytetrafluoro-
ethylene, known as Teflon, is extremely hydrophobic and 
has excellent lubricity. It might provide an ideal stent sur-
face because no mucus would stick to it. However, polytet-
rafluoroethylene is very difficult to process and could not 
be modified for individual applications. For an airway 
stent we need a polymer that has an elastic modulus 
strong enough to counteract a tumor compression but 
enough flexibility to adapt to the complex shape of a tra-
chea. It shall not rupture during the deployment proce-
dure and shall not break after a few thousand coughs. Of 
course, it must be nontoxic and highly biocompatible, as 
well as bacteria-, water- and enzyme-resistant. For the use 
in a 3D printer, it should melt at reasonable temperatures 
(max. 240   °   C) and be stable at body temperature. These 
requirements limit the potential candidates to a much 
smaller group.  
 Nylon, a polyamide invented in 1935, is still used in 
surgical sutures. Nylon threads form the inner structure 
of the Polyflex TM stent (Boston Scientific). We have tried 
various Nylon filaments in our 3D printers. These printed 
stents felt somehow elastic but not as soft and malleable 
as we had hoped. They could not adapt sufficiently to ir-
regular structures and transitions in the animal lungs 
and after initial tests, we abandoned this material for our 
project. 
 Polyurethane, which had once been developed as an 
alternative to Nylon, has similar mechanical properties. 
Thermoelastic polyurethane (TPE) is commonly used in 
medical products including coverings of airway stents. 
The Aero stent TM from Merit Endotek is a hybrid stent 
made from laser-cut nitinol with a flexible polyurethane 
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a b
c d
e f
 Fig. 3. Gastrobronchial fistula in the bron-
chus intermedius after recurrence of 
esophageal cancer (arrow). Tapered bron-
chus below fistula opening. Bronchoscopic 
view ( a ), CT and “virtual bronchoscopy” 
( b, c ). Tailored stent, 3D printed from 
polyurethane, tapered with “sealing” rings 
below and above fistula ( d ). Endoscopic 
views of sealing stent through the bronchus 
( e ) and esophagus ( f ). 
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a b c
 Fig. 2.  a Customized stent for hourglass stenosis directly printed with various thermoplastic polyurethane elastomers.  b Note that the 
wall thickness is slightly higher in the constricted middle part (arrow), while the posterior membrane is thinner. Any variation of local 
wall thickness can be programmed.  c Anatomically shaped silicone stent made by dipping a 3D-printed polylactide core in medical-grade 
silicone. 
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covering. Medical-grade TPE is available for 3D printing 
and we have printed a variety of prototypes as illustrated 
in  Figures 2 a and  3 d. Using the fused filament printing 
technique, the stent can be printed in any shape with ap-
propriate wall thicknesses (local tensile strength). The 
surface of such a printed TPE stent is slightly rough but 
once it has been dipped a few times in or sprayed with 
liquid solved polyurethane the surface gets smooth and 
slippery ( Fig. 4 a). These stents can be easily implanted us-
ing standard rigid bronchoscopes and pushers. We are 
currently evaluating whether they are not inferior com-
pared to commercially available stents regarding mucus 
incrustations and biofilm build-up  [20, 21] . 
 Most polymeric stents are made from silicone; a few 
contain additional other copolymers and additives such 
as barium sulfate to achieve radiopacity. Due to the much 
lower modulus, silicone stents must have thicker walls 
than their metallic counterparts. The most popular stent 
is the one developed by Jean Francois Dumon easily rec-
ognizable because of their migration-preventing struts. 
They are cylindrically shaped and many diameters and 
lengths are available. Special models with 2 or 3 diameters 
for hourglass stenosis can be ordered. Physicians can 
slightly modify these stents on-site by cutting them to a 
desired length or punching side holes for the ventilation 
of a branching segmental bronchus  [22] . However, chang-
ing shapes or transitions are not possible. J-shaped stents 
or stents with branches can only be made by the manu-
facturer and delivery times of weeks have to be accepted. 
 Custom-Made Silicone Stents 
 It is worth exploring how a typical silicone stent is 
made. Polydimethylsiloxane has been brought to mar-
ket in 1943 by Dow Corning. Its flexibility, elongation 
property, tear strength, resistance, and excellent bio-
compatibility make it the almost ideal material for many 
medical devices including implants. At the beginning of 
the manufacturing process, silicone rubber is a highly 
adhesive gel or liquid. In order to convert it to a solid, it 
must be cured, vulcanized, or catalyzed. This is normal-
ly carried out in a two-stage process at the point of man-
ufacturer. A typical medical silicone device is extruded 
or injection molded followed by a prolonged postcure 
process. Siloxanes, once cured, cannot be melted and ex-
truded again. Therefore, medical silicone nowadays 
cannot be used in any of the available 3D printing pro-
cesses. For the extrusion of silicone, normally stainless 
steel molding tools are used. Such molds are precision 
tools that are heavy, costly and take a long time to be 
manufactured. The steel molds need to be trimmed to 
achieve the desired output. A single silicone mold for 
serial production can easily cost a couple of EUR 10,000 
even for fairly basic product designs. Producing custom-
ized stents in a mold suited for serial production is there-
fore economically and timely prohibitive. Low-temper-
ature curing silicones may appear attractive but the pro-
duction process is considered insufficiently reliable for 
implantable devices. 
a b
c
Spraying treated surface
Untreated surface
with grooves
 Fig. 4. Surface treatments of anatomically 
shaped 3D-printed stents.  a Electrospray 
coating for surface smoothing. Scanning 
microscope reveals smoothing effect of 
spray-coated polyurethane. In the untreat-
ed section (left lower corner), grooves from 
the print-head are clearly visible.  b Surface 
of a polyurethane stent treated with antibi-
otic containing nanofibers produced by 
electrospinning.  c Effect of nanocoating on 
wettability: the left stent is nanocoated and 
extremely hydrophobic, the right stent is 
untreated. 
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 In order to overcome this limitation but still be able to 
mold customized silicone stents, we explored some transi-
tion technologies. We wanted to use silicone which is 
probably the best material but also use additive techniques 
that allow mold designs, which are nearly impossible to 
manufacture with traditional machine tools. The typical 
heat for curing silicone is somewhat below 200   °   C. Most 
thermoplastic materials suited for 3D printing will not tol-
erate such a condition. First experiments showed that the 
structure of printed devices and potentially open pore sur-
faces made demolding of the parts difficult. We consid-
ered using chemical additives but as the biocompatibility 
of the product might be negatively affected, we decided to 
avoid releasing agents. In our latest approach, we print 
only the core part of the mold (the “nest”) and embedded 
it by a surrounding steel frame, so that the nest was not 
damaged by the excessive forces caused by the clamping 
force and the injection pressure. We reduced the molding 
temperature to a level that allows the silicone to stabilize 
its shape enough for removal from the mold, and then 
performed the actual curing and postcuring afterwards in 
an oven. As a proof of principle, anatomically shaped 
stents for pigs with a tracheal bronchus and dimensions 
derived from CT data were successfully produced in the 
manufacturing facility of the Bess Company. Seven days 
after submitting the STL files, we could implant these per-
fectly fitting silicone stents in pigs using the standard in-
sertion instruments for Dumon stents ( Fig. 5 c). 
 Colleagues from Spain have developed programs  [23] 
and designed a stent with the focus on ideal mechanical 
properties and have produced prototypes from medical-
grade silicone activated by platinum catalyzers  [24] . Col-
leagues from the Cleveland clinic have implanted a stent 
which they had manufactured in a similar way into a pa-
tient, early this year  [25] . A group from Boston plans a 
clinical study with customized silicone stents according 
to an article in the Boston Globe  [26] . Most recently, col-
leagues from France implanted a 3D planed molded sili-
cone stent in a patient with a posttransplant complex air-
way stenosis  [27] . All these groups use a two-step process 
to create a mold by a rapid prototyping stent technique 
and filling them with silicone. As explained above, these 
production methods require several days. However, ac-
cording to a recent press release, the Wacker Company, a 
leading producer of silicone polymers, has developed a 
3D printing process for silicone which still requires so-
phisticated apparatuses  [28] . If this new technique could 
print medical-grade silicone directly in a desktop printer, 
it could become a true game changer. A directly printed 
silicone stent would be ideal for customization.
 So far, we have shown that it is possible to produce 
customized stents with accessible technologies. Direct 
a b c
d e f
 Fig. 5.  a–c Tracheal bronchus of a pig visualized by CT. Silicone stent made by printing a 3D core from acrylonitrile butadiene styrene 
and dipping in medical-grade silicone ( b ) produced in hospital or by professional injection molding ( c ).  d–f Bronchoscopic image of a 
pig showing the tracheal bronchus ( d ), bronchoscopic images after insertion of hospital-made silicone stent ( e ) and injection molded 
silicone stent ( f ) with tracheal limb.  
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printing with elastomers is theoretically possible in any 
hospital. A physician could offer a solution for an airway 
problem within a few hours. For the time being, stents 
made of medical-grade silicone can only be made by 
molding machines, which requires engineering skills 
( Fig. 6 ). Manufacturing such a stent takes at least a week. 
However, patients with severe dyspnea cannot wait sev-
eral days. Polyurethanes can already be printed and 
stents with acceptable quality can be produced within 
hours. 
 For a patient suffering from a huge gastrobronchial 
fistula, we constructed, printed and inserted such a cus-
tom-made stent. The spilling of bile and gastric fluid into 
a tapered bronchus intermedius could not be stopped 
with a commercially available stent. We printed the stent 
from polyurethane filaments with a tapered shape and 
sealing rings that isolated the destroyed wall from the 
bronchial system ( Fig.  3 ). Using the dimensional data 
from a CT, the “production” of the stent took 5 h. The 
stent was easily inserted, the sealing was almost perfect 
and no side effects were observed. 
 Another option would have been to use the dipping 
techniques with platinum-catalyzed silicone. This is 
equally feasible for temporary prostheses but it is unclear 
whether such a production process will be ever accepted 
by regulatory authorities. Silicone rubber is probably the 
best material and a two-step process by 3D printing of a 
mold, followed by injection of medical-grade silicone and 
curing according to an approved protocol by a certified 
manufacturer seems to be most practical. All methods 
have advantages and disadvantages. The technical aspects 
are summarized in  Table 1 .
 Future Perspectives 
 Mechanical Optimization 
 As already discussed, stents must cope with very dif-
ferent mechanical demands from mild structural aug-
mentation to counteracting lateral tumor compressions 
or circular strictures from scar tissue. There are software 
tools that can predict the behavior of the device under 
a b c
 Fig. 6.  a Complex tracheal stenosis from tumor compression and postoperative distortion.  b Image-based computer model for a 3D 
printer to print injection mold.  c Tailored stent with individualized shapes and localized elastic hoop strengths made from medical-grade 
elastomer.  
 Table 1.  Techniques, advantages, and limitations of various methods for productions of customized airway stents
Manufacturing  method Production
location
Shape, dimensions Shore
hardness
Wall thickness,
local recoil
Time to
implant
3D printed with soft elastomer on site in hospital any limited completely variable 5 h
3D printed core silicone dipping potentially in hospital straight stents only fixed fixed 12 h
Silicone injection molded device company any any slightly variable 5 days
Co
lo
r v
er
si
on
 a
va
ila
bl
e 
on
lin
e
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
Ze
nt
ra
lb
ib
lio
th
ek
 Z
ür
ich
   
   
   
 
13
0.
60
.4
7.
13
6 
- 1
/2
3/
20
18
 4
:1
5:
54
 P
M
 Custom-Made Stents Respiration 2017;94:442–456
DOI: 10.1159/000479164
451
mechanical influences such as compression from specific 
points. The most commonly used technique is finite ele-
ment analysis  [24, 29] . Impressive color images show a 
what-if scenario and allow optimization during the de-
sign process. These tools are great if the parameters are 
known. Material constants, such as the elastic modulus 
and the wall thickness as well as all geometrical data from 
the prosthesis, can be fed in. However, the remaining un-
known factor is the constricting force of the tissue as there 
are not feasible instruments that could measure these 
forces. Such a measuring tool would be very helpful. Our 
own experiments failed as the devices that we built were 
too fragile and could not be sterilized  [30] . Some informa-
tion about the tissue biomechanics can be gathered from 
imaging data but so far, there is no perfect solution. A 
Spanish group noted that the mathematical analysis for 
their stent optimization required high expertise and many 
hours of processing time on a high-power computer  [24] . 
This is not practical for rapid action in a clinical setting 
and for the time being we have to accept some degree of 
uncertainty. However, the outlined approach of coopera-
tion between the bronchoscopist who has examined the 
patient and “touched and felt” his airways and material 
engineers who know their tools and can influence the lo-
cal stent properties is certainly a more promising ap-
proach than using the same stent with the same recoil for 
all indications. 
 Surface Treatment 
 There are other approaches that will certainly merge 
with the presented 3D production techniques. As men-
tioned before, one of the most annoying problems with 
stents is the impaction or even incrustation with mucus. 
While Teflon stents will be difficult to make, plasma treat-
ment or surface coating with repellent molecules can cer-
tainly be accomplished. The spray technique that we used 
for the stents in  Figure 4 has broad applications in hy-
giene and household products. No mucus can stick to 
such a treated surface. However, these coating materials 
and sprays do not have any approval for medical im-
plants. The same holds true for antibacterial coatings. 
Bacterial colonization and biofilm formation is a well-
known problem with any type of implant  [31, 32] . Surface 
roughness and porosity of implants probably facilitate 
microbial adhesions, biofilm build-up, and infections. In-
trinsically antimicrobial polymers are attractive. They ei-
ther repel or actively kill bacteria. Typical chain extenders 
of polyurethanes, e.g., hyaluronic acid or additives such 
as poly-N-vinylpyrrolidone, inhibit the adhesion of 
 Staphylococcus epidermidis and  Staphylococcus aureus . 
Active killing is accomplished by adding chemical sub-
stances (chlorhexidine), metal ions (silver) or antibiotics 
(minocycline, rifampicin)  [33] . While these strategies 
have been followed extensively for intravascular prosthe-
ses, there are no comparable airway products. All major 
manufacturers of airway stents are reluctant to change 
their existing products. Technically, there are at least two 
feasible options for 3D-printed stents: silver nanoparti-
cles or copper ions could be incorporated into the print-
ing material, or coatings could be added after the product 
has been printed. Though such an approach might lower 
infection rates and prevent halitosis, gaining a CE mark 
or FDA approval would be too costly for the time being 
 [34] . Mixing antibiotics into the above-mentioned mate-
rials would not be feasible as the melting temperature is 
too high. Another option would be combining the hot 
fused filament techniques (temperature approx. 200   °   C) 
or the injection mold technique with a secondary “cold” 
technique such as wet printing or electrospinning  [35–
37] . It has been shown that antibiotics can be incorpo-
rated in polymers and preserve sufficient antibacterial 
power. Technically, it is possible to add drugs, e.g., by 
electrospraying to the surface of a printed stent, even tai-
lored to the particular infection strain of a patient as dem-
onstrated in  Figure 4 c. 
 Drug-Eluting Stents 
 Obviously, the next step would be to transform a regu-
lar stent into a truly eluting device. Stents that release 
drugs over time are attractive in oncology  [38] and could 
gain broad application. Tumor ingrowth into stents could 
be prevented. Incorporated antifibrotic drugs could tar-
get granulation tissue formation  [39, 40] . The technical 
hurdles can be overcome even with low sophisticated 
equipment ( Fig. 4 ,  7 ) but adding drugs to a stent which is 
a passive medical device would transform it into a phar-
maceutically active product with more unsolved liability 
issues. It comes down to the same question, who would 
be legally allowed to fill such a device. Stent companies 
are not pharmaceutical companies and practitioners can-
not take the responsibility either.  
 Biodegradable Stents 
 Regardless of how good a stent is, it remains a foreign 
body and will always have side effects. For some cases, it 
would be preferable to have a stent that vanishes over 
time in a predictable manner. Basically, a stent should 
disappear once it has accomplished its task without leav-
ing traces. For the vascular system, several solutions are 
already available, while biodegradable airway stents are 
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in their early infancy  [12, 41, 42] . We are currently test-
ing 3D-printed biodegradable stents in the animal labo-
ratory. 
 Stents Changing over Time 
 3D printing is definitely not the last step in the evolu-
tion that we are observing. Further developments and 
modifications have the potential to create a truly new 
class of devices. Spatial adaption is certainly important. 
The optimized stent should adapt to the geometry as per-
fectly as possible. However, tissue conditions change over 
time. Any biological structure under pressure, whether a 
malignant tumor or a benign scar, has a viscoplastic be-
havior. Under the expanding force of a stent, a stenosis 
will slowly open and once it is wide enough, the friction 
is gone and the stent can migrate. A pediatric stent cannot 
grow with the child and will eventually become the limit-
ing structure in an otherwise expanding trachea. Ideally, 
we would have a stent that changes over time, e.g., ex-
panding a stricture slowly over several days or weeks. It 
would not rupture the tissue after deployment but would 
not migrate later on either. Shape memory alloys such as 
nitinol have the ability to recover to a former shape. We 
had tried stents that expanded to a desired diameter at 
body temperature. Technologically interesting, they had 
no advantages over self-expanding metal stents and none 
of these experimental devices has made it to clinical use. 
Polymers have a much greater potential  [43] . Using smart 
polymers can advance 3D printing one step – or rather 
one dimension further. The new label is 4D printing. De-
vices can be printed with materials that can adapt and 
exhibit behavior in response to environmental changes or 
just over time. A simple example is presented in  Figure 8 . 
We printed a hybrid stent from an elastic polymer (poly-
urethane) and a second restricting polymer (polylactic 
acid) that degrades in vivo. This would be the simplest 
form of a “growing” stent. Other groups work on far more 
sophisticated technologies. Skylar Tibbits and his co-
workers  [44] have presented self-evolving 3D structures. 
Using a commercially available multimaterial 3D printer, 
they have created a straight wire that transforms itself into 
a cube when the temperature changes. Using new smart 
materials, it is possible to print and create objects that can 
exert forces and change shapes in predictable ways. Spa-
tial and temporal adaptions can be programmed with bi-
ological aspects  [45] . It will probably take a few years un-
til these technologies will be accessible but there are al-
ready great opportunities using available devices and 
 Fig. 7. Self-developed 3D multimode, multimaterial printer, able to print and photocure various polymers and 
coverings with repellent substances or drugs and capabilities of robo spinning and electrospinning. 
 Fig. 8. Approaches towards 4D stents. Combination of degradable 
and stable elastic polymers. Degradation of the restraining element 
makes a slowly dilating stent. 
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materials. The opportunities seem endless. Anatomically 
shaped, smart responding, partially degrading, drug-elut-
ing, antibacterially coated stents that are rapidly pro-
duced on-site can become clinical reality very soon. In 
cooperation with an engineering company (2PrintBeta), 
we have developed a very versatile multimode printer. 
This machine ( Fig. 7 ) can not only print various polymers 
with the fused filament technique but it can also add coat-
ings with polymers, nanoparticles, antibiotics, antiprolif-
erative drugs and even cells. It has lasers for photopoly-
merization, motors for robo spinning and a high voltage 
source for electrospinning built in. This is still work in 
progress and we do not expect it to become a commercial 
product, but it helps to make our prostheses for experi-
mental work. 
 Despite all optimism, we have to accept that stents are 
still foreign bodies. They do impair mucus clearance and 
they affect the tissue just by applying surface pressure. 
Regardless, how well we can design and produce a stent 
it will always be irritating. Tissue engineering techniques 
may one day allow to print true replacements for a dis-
eased airway but for the time being can only try to opti-
mize artificial prostheses. Many promising techniques 
are available; the limitations are mainly on the regulatory 
side. 
 Legal Aspects in General 
 The classical textbook on biocompatibility and perfor-
mance of medical devices by Jean-Pierre Boutrand  [46] 
emphasizes that only multidisciplinary approaches have 
chances to transform ideas into devices that can be im-
planted in patients. It deals with the obvious problem that 
we all expect new, superior devices, as soon as possible 
but also at least as safe as the existing ones. 3D printing is 
an example of this challenge in a nutshell. Using an ama-
teur printer, we can make stents that fit better than any 
existing prosthesis but nobody wants to take the respon-
sibility for possible device failures. 
 Fifty years ago, clinical anesthesiologists expressed 
their concerns about the safety of tracheal devices made 
from polymers. These physicians made suggestions and 
their initiatives helped to develop biocompatibility tests 
 [47] . Today, any medical product has to undergo a battery 
of strict tests proving long-term safety  [48, 49] . They are 
outlined in international standards and national guide-
lines for medical devices. ISO 10993 regulates the bio-
compatibility evaluation and tests required for devices 
that are directly or indirectly in contact with the body. 
The FDA follows the Medical Device Amendment of the 
US Food and Drug Act of 1976 and 1990 and requires 
even more in vitro and in vivo tests. Implanted stents fall 
in the category of implantable devices intended to be in-
troduced into the human body and remain after the pro-
cedure. Of course, biological testing for chemical inert-
ness, cytotoxicity, carcinogenicity, genotoxicity, and ad-
verse immunological reactions are necessary to prove 
biocompatibility and biodurability of all used materials as 
well as the final product. Device efficacy and functionality 
including fatigue resistance, mucus accumulation, migra-
tion etc. are usually checked in meticulous laboratory 
bench tests and long-term animal trials. Without comply-
ing with the EU Medical Device Directive 93/42/EEC, no 
device may be sold or used in the EU.
 For good reasons, regulatory authorities have taken 
over the responsibility and the initiative from physicians 
and inventors. As a result of these measures that have 
been put in place for risk minimization, the necessary pa-
per work and the liability issues that would permit a clini-
cian to develop and produce something for his patient 
are, mildly speaking, discouraging. There are problems in 
every step of the process. For example, the open access 
software package 3D Slicer 4.0 that is perfectly suited to 
import DICOM data, perform segmentation and export 
the files to load into the CAD program to generate the 
printer instructions has been developed by the National 
Alliance for Medical Image Computing, funded by the 
National Institute of Health. However, it states clearly 
that this software package is not an FDA-approved med-
ical device. Using the pulmonary module of the Materi-
alise Mimics Care Suite (Materialize, Brussels, Belgium), 
which is the best established software solution for medical 
printing in Europe, and following all recommendations 
does not mean that any further approval process could be 
skipped. None of the printers that we as physicians have 
access to does have approval for manufacturing of medi-
cal devices. The discussed printing materials do not fulfill 
the requirements that are standard in the pharmaceutical 
industry. The outlined processes of rapid additive pro-
duction of a stent in a hospital setting are incompatible 
with current good manufacturing principles and ISO 
standards. Of course, the risk must be as small as possible 
but it is not justified to withhold help for a suffocating 
patient because there might be a potential side effect. 
Some loop holes might exist that would allow manufac-
turing a temporarily used device in a hospital that would 
help a patient for a few days. Swiss regulations, for ex-
ample, permit these types of experimental therapies, if 
two independent disciplines state that there are no other 
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treatment options. However, stents for long-term use 
must be produced under good manufacturing principles 
conditions. For the particular problem of 3D-printed de-
vices, the FDA has had a hearing and has provided sug-
gestions how the process could be facilitated without 
jeopardizing the patient’s safety  [50] . None of these rec-
ommendations has any binding legal power but a process 
has been started  [51] . To our knowledge, European au-
thorities have not released any helpful guidelines, neither 
for practitioners nor for industrial partners. 
 Legal Situation (Europe) for a Professionally 
Manufactured Individual Stent 
 To bring a customized stent to the market, the medical 
device manufacturer must meet a couple of requirements. 
Even if a specific stent design is prescribed by the physi-
cian, the manufacturer must assure that the stent is prop-
erly manufactured and fulfills the essential requirements 
for a medical device. These essential requirements are de-
fined in Europe by the European Medical Device Direc-
tive (MDD, annex I). In annex VIII of the MDD, the nec-
essary documentation for a custom-made device is de-
fined. 
 Basically, custom-made devices do not carry a CE 
mark but the words “custom-made device.” The manu-
facturer provides basic information about the product 
and warrants that the so-called essential requirements are 
fulfilled. The fitness of the stent for the particular indica-
tion of that individual patient lies within the responsibil-
ity of the physician. The manufacturer holds detailed re-
cords on file for the competent authorities, in case of cus-
tom-made stents for a period of 15 years. Further local 
requirements may occur. To be able to demonstrate that 
a product fulfills the essential requirements, the manufac-
turer typically has to maintain a quality assurance system 
that includes design and production controls. Design 
controls for instance require strict adherence to risk man-
agement standards, standards for product safety (e.g., 
biocompatibility), or product-specific type of standards. 
Product performance tests and data are also part of the 
design controls. Production controls include all sorts of 
production environment requirements (e.g., cleanroom), 
sterilization, raw material control, avoiding production 
and labeling errors, etc. All relevant production steps are 
subject to validation and inspection procedures. 
 It is the responsibility of the competent regional au-
thority to keep custom-made manufacturers under their 
surveillance. So, even if custom-made products do not 
carry a CE mark, there are practically the same regulatory 
requirements to fulfill and the same level of general prod-
uct safety to achieve. 
 Summary and Outlook 
 It has been shown, that the use of 3D printing tech-
niques is capable of manufacturing custom-made devices 
made of silicone or elastic thermoplastics. 3D printing 
technologies are accessible for physicians. An optimized 
stent could be produced in a normal hospital laboratory. 
It could be surface coated and even drug eluting. Though 
technically feasible, liability issues will probably make 
this approach impossible. A reasonable compromise 
would be to provide software tools that would enable the 
bronchoscopist to create an instruction file in an interac-
tive manner and send this file to a certified manufacturer 
who produces and sterilizes this tailored stent. This spe-
cific process enables the practitioner to receive a stent, 
which is perfectly adapted to the indication in a fast way 
and with reasonable costs. Additionally, it is possible to 
manufacture products with geometries, which are almost 
impossible to manufacture with existing processes. How-
ever, there are still many open questions. Not only the 
biocompatibility and stability of the finished products has 
to be guaranteed, but also the design and manufacturing 
processes have to be validated and optimized to achieve a 
reproducible and safe product. Adding further features 
such as biodegradability, controlled drug release or pre-
dictable deformation (growth) is technically feasible but 
the legal pathways are huge hurdles and the costs involved 
might prevent industry partners from addressing the un-
met need of a truly optimized airway stent. Continuing 
(US) or starting (Europe) a constructive dialog between 
physicians, manufacturers and regulatory authorities is 
most needed.
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